DEGASPERI, ELISABETTA

DEGASPERI, ELISABETTA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 41 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review 2023 Elisabetta DegasperiMaria Paola AnolliPietro Lampertico Article (author) -
Bulevirtide for patients with compensated chronic hepatitis delta: A review 2022 Elisabetta DegasperiMaria Paola AnolliPietro Lampertico Article (author) -
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR 2022 Degasperi EAnolli MPFanetti ISoffredini RTosetti GPerbellini RSangiovanni ALampertico P. + Article (author) -
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension 2022 Degasperi EAnolli MPUceda Renteria SCPerbellini RFacchetti FLoglio ALampertico P. + Article (author) -
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 2022 Valenti L.Pelusi S.Aghemo A.Pasulo L.Degasperi E.D'Ambrosio R.Zuccaro V.Giorgini A.Rumi M. G.Spinelli O.Colombo M. C.Menzaghi B.D'Arminio Monforte A.Bonfanti P.Lampertico P. + Article (author) -
Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting antivirals in terms of prediction of hepatocellular carcinoma—authors' reply 2022 Degasperi E.D'Ambrosio R.Lampertico P. Article (author) -
The relationship between liver histology and thyroid function tests in patients with nonalcoholic fatty liver disease (NAFLD) 2021 D'Ambrosio R.Campi I.Perbellini R.Stucchi R.Degasperi E.De Silvestri A.Persani L.Fugazzola L.Lampertico P. + Article (author) -
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy 2021 Degasperi ELampertico P + Article (author) -
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy 2021 Tosetti G.Degasperi E.Farina E.D'Ambrosio R.Soffredini R.Borghi M.La Mura V.Lampertico P. + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 2021 Cristoferi L.Degasperi E.Cerini F.Malinverno F.Ronca V. + Article (author) -
Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs 2020 Degasperi, ElisabettaGalmozzi, EnricoPelusi, SerenaD'Ambrosio, RobertaSoffredini, RobertaPerbellini, RiccardoFacchetti, FlorianaIavarone, MassimoValenti, LucaLampertico, Pietro + Article (author) -
ASSOCIAZIONE TRA SCORE GENETICO GRS E RISCHIO DI EPATOCARCINOMA IN PAZIENTI CON CIRROSI HCV TRATTATI CON FARMACI ANTIVIRALI DIRETTI 2020 DEGASPERI, ELISABETTA Doctoral Thesis -
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 2020 Lapadula G.Valsecchi M. G.Carriero C.Degasperi E.Pasulo L.Baiguera C.Menzaghi B.Lombardi A.Aghemo A.Rumi M. G.Valenti L.De Bona A.d'Arminio Monforte A.Bonfanti P.Perini P.Capretti A.Ciaccio A.Lampertico P. + Article (author) -
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 2019 Lampertico, PietroZuin, MassimoDegasperi, ElisabettaGiorgini, Alessia M.Bollani, Simona + Article (author) -
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 2019 Tosetti, GiuliaLa Mura, VincenzoD'Ambrosio, RobertaDegasperi, ElisabettaMezzina, NicolòViganò, MauroRumi, MariagraziaFracanzani, Anna LudovicaLombardi, RosaFargion, SilviaAghemo, AlessioLampertico, Pietro + Article (author) -
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure 2019 Degasperi, ElisabettaLombardi, AndreaPasulo, LuisaGiorgini, AlessiaGatti, FedericoBonfanti, PaoloAghemo, AlessioSoffredini, RobertaLampertico, Pietro + Article (author) -
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals 2019 Degasperi, EGalmozzi, EFarina, ELampertico, P + Article (author) -
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 2018 P. LamperticoM. ZuinE. DegasperiGIORGINI, ALESSIA MARIAS. Bollani + Article (author) -
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 2018 E. DegasperiR. D'AmbrosioR. PerbelliniS. De NicolaP. Lampertico + Article (author) -